CHRONIC FATIGUE & ME/CFS
Chronic Fatigue Blood Test UK: The Biomarkers That Distinguish ME/CFS from Treatable Conditions
You've been exhausted for months. Not the ordinary tiredness that lifts after a weekend off — a bone-deep fatigue that sleep doesn't fix, that worsens after physical or mental effort, and that has slowly dismantled your ability to live normally. You've seen your GP. They ran some bloods. Everything came back “normal.”
That word — “normal” — is where the problem starts. An estimated 250,000 people in the UK live with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). The average time to diagnosis is 3.6 years. During that time, many patients cycle through repeated blood tests that check a narrow range of markers — and miss both the treatable conditions that mimic ME/CFS and the physiological patterns that point towards it.
This guide covers the blood tests that NICE NG206 recommends for suspected ME/CFS, the additional markers that reveal treatable mimics, how to read the results when they come back, and what to do when “normal” bloods leave you no closer to an answer.
ME/CFS Is Not “Just Being Tired”
Myalgic encephalomyelitis / chronic fatigue syndrome is a complex, multi-system condition. The NICE NG206 guideline (2021) defines it by four core features: debilitating fatigue that is not proportional to activity, post-exertional malaise (a worsening of symptoms after physical or cognitive effort), unrefreshing sleep, and cognitive difficulties. These must have persisted for at least 3 months in adults and cannot be explained by another diagnosis.
The critical distinction: ME/CFS is a diagnosis of exclusion. Before a clinician can diagnose it, they must rule out the treatable conditions that produce similar symptoms — hypothyroidism, iron-deficiency anaemia, coeliac disease, diabetes, adrenal insufficiency, and autoimmune conditions. Blood tests are the primary tool for this exclusion process.
The problem is that many patients receive an incomplete panel. A basic FBC and thyroid check may catch the most obvious mimics, but it misses the subtler patterns — subclinical thyroid dysfunction, early iron depletion before haemoglobin drops, low-grade inflammation, vitamin D deficiency, and cortisol dysregulation — that either explain the fatigue outright or compound the burden of ME/CFS itself.
What NICE NG206 Says to Test
The NICE NG206 guideline recommends the following investigations before diagnosing ME/CFS. These are the minimum — not a comprehensive assessment:
| NICE NG206 Test | What It Rules Out |
|---|---|
| Full blood count (FBC) | Anaemia, infection, haematological conditions |
| Urea & electrolytes | Kidney disease, electrolyte imbalance |
| Liver function tests | Liver disease, alcohol-related damage |
| Thyroid function (TSH) | Hypothyroidism, hyperthyroidism |
| ESR or CRP | Active inflammation, autoimmune conditions |
| Calcium & phosphate | Hypercalcaemia, parathyroid disease |
| HbA1c or fasting glucose | Diabetes, pre-diabetes |
| Ferritin | Iron deficiency (even without anaemia) |
| Coeliac serology (tTG-IgA) | Coeliac disease |
| Creatine kinase | Muscle disease (myositis, myopathy) |
| Urinalysis | Kidney disease, diabetes, infection |
This list is essential but incomplete. NICE NG206 explicitly states that clinicians should use “clinical judgement to investigate other possible diagnoses” — meaning the above is a floor, not a ceiling. Additional markers like vitamin D, cortisol, B12, and autoimmune antibodies (ANA) can catch conditions that the standard panel misses entirely.
The 10 Biomarkers That Matter for Chronic Fatigue
These are the markers that, together, distinguish between treatable causes of fatigue and the physiological pattern associated with ME/CFS. Each is listed with the specific reason it matters in the context of chronic fatigue — not its general clinical purpose.
Hypothyroidism is the single most common treatable mimic of ME/CFS. TSH alone catches overt hypothyroidism, but a 'normal' TSH between 3.0–5.0 mU/L can mask subclinical thyroid dysfunction — particularly in patients whose pre-illness TSH was closer to 1.0–2.0. FT4 and FT3 reveal whether the thyroid is actually converting T4 to the active T3 hormone. Poor T4→T3 conversion (low FT3 with normal FT4) is associated with fatigue, brain fog, and cold intolerance even when TSH is technically 'in range'.
NICE CG145 · BMJ Best Practice: Hypothyroidism
Iron deficiency causes fatigue long before it causes anaemia. The NHS lower reference limit for ferritin is typically 15–30 µg/L, but fatigue symptoms can appear at levels below 50 µg/L. A ferritin of 20 is 'normal' by lab standards but associated with significant fatigue, restless legs, and exercise intolerance. In the context of chronic fatigue, ferritin below 50 is worth investigating — especially in menstruating women, vegetarians, and frequent blood donors.
BSH Guideline on Iron Deficiency 2021 · Lancet 2012;380:1749–61
Vitamin D deficiency affects an estimated 1 in 5 UK adults. Symptoms overlap heavily with ME/CFS: fatigue, muscle pain, cognitive impairment, and low mood. Levels below 50 nmol/L are considered insufficient by SACN guidelines, yet many patients with chronic fatigue are never tested. Correction of deficiency (supplementing to 75–100 nmol/L) can meaningfully improve energy in patients whose fatigue has a nutritional component.
SACN Vitamin D Report 2016 · NICE NG34
Standard CRP detects acute inflammation (infection, injury). hs-CRP detects the low-grade chronic inflammation increasingly associated with ME/CFS. Studies have found elevated hs-CRP (1.0–3.0 mg/L) in ME/CFS patients even when standard CRP appears normal. This matters because chronic low-grade inflammation drives fatigue through cytokine-mediated mechanisms — and it’s modifiable through diet, exercise, and targeted supplementation.
Brain, Behavior, and Immunity 2019;75:206–16 · Lancet Neurology 2020;19:165–74
Blood sugar dysregulation is both a mimic and a complicator of chronic fatigue. An HbA1c of 42–47 mmol/mol (pre-diabetes range) indicates insulin resistance — a condition where cells struggle to access glucose for energy despite adequate blood sugar levels. The resulting energy crashes, brain fog, and post-meal fatigue overlap precisely with ME/CFS symptoms. Catching pre-diabetes changes the treatment plan entirely.
NICE NG28 · WHO HbA1c criteria 2011 · Diabetes Care 2019;42(Suppl 1)
B12 deficiency causes fatigue, cognitive impairment, paraesthesia, and mood disturbance. The NHS lower limit (typically 180–200 ng/L) misses the 'grey zone' between 200–350 ng/L where deficiency symptoms can already be present. B12 is particularly relevant in patients taking metformin or proton pump inhibitors (PPIs), both of which impair absorption. In chronic fatigue, checking both serum B12 and methylmalonic acid (MMA) gives the clearest picture.
BSH Guidelines B12/Folate 2014 · NICE CKS: Vitamin B12 Deficiency
The FBC is the broadest screening net in the ME/CFS workup. Beyond haemoglobin (anaemia), it reveals white cell abnormalities (infection, haematological conditions), platelet counts (autoimmune, liver), and red cell indices (MCV for B12/folate deficiency, MCH for iron). A raised lymphocyte count can suggest ongoing viral activity. A low white cell count may point towards autoimmune neutropenia. Every chronic fatigue workup starts here.
NICE NG206 · BSH FBC Interpretation Guideline
Cortisol dysregulation is one of the most consistent biochemical findings in ME/CFS research. A flattened diurnal cortisol curve (low morning cortisol, blunted evening dip) is associated with fatigue, unrefreshing sleep, and poor stress recovery. A very low morning cortisol (below 100 nmol/L on a 9am sample) warrants investigation for adrenal insufficiency — a rare but serious condition that mimics ME/CFS precisely. NICE NG206 does not include cortisol as a standard investigation, but the Endocrine Society recommends it when fatigue is unexplained by initial screening.
Psychoneuroendocrinology 2014;39:141–54 · Endocrine Society Clinical Practice Guideline: Adrenal Insufficiency 2016
Coeliac disease affects around 1 in 100 people in the UK, and up to 75% are undiagnosed. Fatigue is the presenting symptom in roughly a third of coeliac patients — sometimes without any gastrointestinal symptoms at all. The tissue transglutaminase IgA (tTG-IgA) antibody test is the recommended first-line screen. A positive result requires duodenal biopsy for confirmation. NICE NG206 explicitly includes coeliac serology in the ME/CFS workup because the overlap in symptoms is so high.
NICE NG20 (Coeliac Disease) · BSG Guideline 2019 · Gut 2019;68:1269–1278
Systemic lupus erythematosus (SLE), Sjögren’s syndrome, and other connective tissue diseases cause fatigue, joint pain, and cognitive dysfunction that overlap with ME/CFS. ANA is the standard screening antibody. A positive ANA (titre ≥1:160) with compatible symptoms warrants specialist referral for autoimmune workup. NICE NG206 does not include ANA by default, but it is routinely added when patients present with fatigue plus joint pain, rashes, dry eyes, or Raynaud’s phenomenon.
BSR Guideline on SLE 2018 · NICE CKS: Systemic Lupus Erythematosus
NHS vs Optimal Ranges: Why “Normal” Doesn't Mean “Healthy”
NHS reference ranges are designed to detect disease, not optimise function. A result that falls within the reference range may still be suboptimal for energy, cognition, and recovery. This table shows the difference.
| Marker | NHS Reference | Optimal for Energy |
|---|---|---|
| TSH | 0.27–4.2 mU/L | 1.0–2.5 mU/L |
| Ferritin | 15–300 µg/L | ≥50 µg/L (some guidelines suggest ≥70) |
| Vitamin D | ≥25 nmol/L (sufficient) | 75–100 nmol/L |
| hs-CRP | <5 mg/L | <1.0 mg/L |
| HbA1c | <42 mmol/mol | <36 mmol/mol |
| B12 | 180–900 ng/L | >500 ng/L |
| Cortisol (9am) | 140–690 nmol/L | 400–550 nmol/L |
| Haemoglobin (F) | 115–160 g/L | 130–150 g/L |
| Haemoglobin (M) | 130–175 g/L | 145–165 g/L |
Key point: A patient with TSH 3.8, ferritin 25, vitamin D 35, and B12 220 would receive “all normal” from most NHS labs. Every single one of those values is suboptimal for energy. Together, they create a cumulative burden that feels exactly like ME/CFS — but is entirely correctable.
6 Treatable Conditions That Mimic ME/CFS
Before settling on a ME/CFS diagnosis, these conditions must be confidently excluded. Each can produce identical symptoms and each has a specific, effective treatment.
Hypothyroidism
Symptom overlap: Fatigue, brain fog, cold intolerance, weight gain, muscle aches
Key test: TSH + FT4 + FT3
Treatment: Levothyroxine (T4 replacement)
NICE CG145
Iron Deficiency (with or without anaemia)
Symptom overlap: Fatigue, exercise intolerance, restless legs, breathlessness
Key test: Ferritin + FBC
Treatment: Oral or IV iron replacement
BSH 2021
Coeliac Disease
Symptom overlap: Fatigue, brain fog, joint pain, abdominal symptoms (sometimes absent)
Key test: tTG-IgA + total IgA
Treatment: Strict gluten-free diet
NICE NG20
Type 2 Diabetes / Pre-diabetes
Symptom overlap: Fatigue, brain fog, post-meal energy crashes
Key test: HbA1c
Treatment: Dietary intervention, metformin if indicated
NICE NG28
Adrenal Insufficiency
Symptom overlap: Fatigue, dizziness on standing, salt craving, weight loss
Key test: 9am cortisol + Synacthen test
Treatment: Hydrocortisone replacement
Endocrine Society 2016
Systemic Lupus Erythematosus (SLE)
Symptom overlap: Fatigue, joint pain, cognitive dysfunction, skin rashes
Key test: ANA + anti-dsDNA + complement C3/C4
Treatment: Hydroxychloroquine, immunosuppressants
BSR 2018
5 Blood Test Result Patterns in Chronic Fatigue
Chronic fatigue rarely has a single cause. These are the five most common result patterns we see — each pointing to a different underlying driver and a different course of action.
Pattern 1: The Thyroid First
Typical markers: TSH 3.5–5.0, FT4 low-normal, FT3 low
What it means: Subclinical hypothyroidism or poor T4→T3 conversion. Your thyroid is doing the minimum — enough to stay 'in range' but not enough to support normal energy and cognition. Often worsened by low selenium, iron, or iodine.
What to do: Discuss trial of levothyroxine with your GP. Recheck in 6–8 weeks. If TSH is above 10 or FT4 is below range, treatment is standard per NICE CG145.
Pattern 2: The Iron-Depleted Exhaustion
Typical markers: Ferritin 15–40, Hb normal (120–140), MCV normal or low-normal
What it means: Iron stores are depleted but haemoglobin hasn't dropped yet. This is 'iron deficiency without anaemia' — a common and underdiagnosed cause of fatigue, particularly in menstruating women. Your body is compensating by pulling iron from stores, which works until it doesn't.
What to do: Iron supplementation (ferrous fumarate 210mg daily or alternate-day dosing per BSH guidelines). Recheck ferritin at 8–12 weeks. Aim for ferritin ≥50.
Pattern 3: The Nutritional Stack
Typical markers: Vitamin D <50, B12 200–350, ferritin <50
What it means: Multiple concurrent deficiencies. Each one alone might produce mild fatigue. Together, they create a cumulative energy deficit that feels like a systemic condition. This pattern is especially common in vegans, people on PPIs or metformin, shift workers, and those who rarely get outdoor sun exposure.
What to do: Targeted supplementation: vitamin D 3,000–4,000 IU daily with K2, B12 1,000 µg sublingual or IM injection if absorption is impaired, and iron if ferritin is low. Recheck all three at 3 months.
Pattern 4: The Inflammatory Smoulder
Typical markers: hs-CRP 1.5–4.0, ESR mildly raised, ferritin raised (paradoxically)
What it means: Chronic low-grade inflammation. Ferritin is an acute-phase reactant — it rises with inflammation, which can mask underlying iron deficiency. The fatigue here is cytokine-driven: your immune system is chronically activated, consuming energy resources. This pattern is common post-COVID and in autoimmune conditions.
What to do: Investigate the source of inflammation. Consider ANA, anti-dsDNA, and complement if autoimmune cause suspected. Anti-inflammatory dietary patterns (Mediterranean diet, omega-3 supplementation) have modest but consistent evidence. If hs-CRP is persistently elevated, your GP may consider referral to rheumatology.
Pattern 5: The True ME/CFS Profile
Typical markers: All standard markers normal or near-optimal. Cortisol curve flattened. No treatable cause found.
What it means: When a comprehensive panel comes back normal — not 'normal' by narrow NHS ranges but genuinely optimal — and post-exertional malaise is the dominant symptom, the working diagnosis is ME/CFS. Current research points to immune dysregulation, mitochondrial dysfunction, and autonomic nervous system impairment, none of which are detectable on standard blood tests.
What to do: Request GP referral to a specialist ME/CFS service (NICE NG206 recommends this for all patients meeting diagnostic criteria). Focus on pacing as the primary management strategy. Avoid graded exercise therapy (GET) — NICE NG206 explicitly removed GET from recommended treatments in 2021.
Post-Exertional Malaise and Blood Markers
Post-exertional malaise (PEM) is the hallmark symptom that separates ME/CFS from other causes of chronic fatigue. It's defined as a disproportionate worsening of symptoms following physical, cognitive, or emotional exertion — often delayed by 12–72 hours and lasting days to weeks.
Current research suggests PEM may involve impaired cellular energy production (mitochondrial dysfunction), abnormal immune activation after exertion, and autonomic nervous system dysregulation. Standard blood tests cannot detect these mechanisms directly. However, some patients show transient changes in hs-CRP and cortisol following exertion that are not seen in healthy controls.
Practical implication: If your blood tests come back normal but you experience unmistakable PEM — where a 30-minute walk today means you cannot function for three days afterwards — the normal results do not invalidate your experience. They indicate that the pathology is happening at a level standard blood tests were not designed to detect. This is precisely the diagnostic pattern NICE NG206 describes.
GP vs Private Testing for Chronic Fatigue
| Factor | NHS / GP | Helvy |
|---|---|---|
| Markers tested | FBC, TSH, CRP, HbA1c, ferritin, coeliac, U&E, LFT, calcium | 50+ biomarkers including all NICE NG206 markers plus hs-CRP, FT3, cortisol, vitamin D, B12, ANA |
| Reference ranges | Standard NHS population ranges | Optimal ranges with clinical context |
| Turnaround | 1–2 weeks (GP appointment + lab + follow-up) | 5 working days from sample receipt |
| Interpretation | GP review (often 'all normal' if in range) | Detailed results with pattern analysis |
| Cost | Free (NHS) | From £89 (Essential panel) |
| Repeat testing | Usually resisted within 12 months | Test as often as needed |
| Sample method | Venous draw at phlebotomy clinic | Home finger-prick or venous draw |
Private testing does not replace a GP. If your blood tests reveal a treatable condition (thyroid, coeliac, diabetes), you will need NHS follow-up for treatment. What private testing provides is a more comprehensive initial picture — catching the conditions and sub-optimal patterns that a standard NHS panel may miss on the first pass.
Which Helvy Panel Covers What
For a thorough chronic fatigue workup, you want coverage across thyroid, iron, inflammation, metabolic, and nutritional markers. Here's how our panels map to the 10 key biomarkers:
| Biomarker | Essential (£89) | Performance (£129) |
|---|---|---|
| TSH | ✓ | ✓ |
| FT4 + FT3 | — | ✓ |
| Ferritin | ✓ | ✓ |
| Vitamin D | ✓ | ✓ |
| hs-CRP | ✓ | ✓ |
| HbA1c | ✓ | ✓ |
| B12 | ✓ | ✓ |
| FBC | ✓ | ✓ |
| Cortisol | — | ✓ |
| Coeliac / ANA | — | — |
Best choice for chronic fatigue: The Performance panel covers 8 of the 10 key markers including FT3 and cortisol. For coeliac screening and ANA, ask your GP — these are readily available on the NHS and are usually the first tests ordered when ME/CFS is suspected.
What to Do With Your Results
Check for treatable causes first
If any marker flags a clear treatable condition (TSH out of range, ferritin very low, HbA1c in diabetic range, tTG-IgA positive), book a GP appointment immediately. These have specific, effective treatments and should not be managed with supplements alone.
Look at the suboptimal pattern
If everything is 'in range' but multiple markers sit at the suboptimal end (see the ranges table above), the cumulative burden may be driving your fatigue. Discuss targeted supplementation and lifestyle changes with your GP or a registered nutritionist.
Rule out inflammation
If hs-CRP is elevated (>1.0 mg/L) without an obvious acute cause, discuss with your GP. Persistent low-grade inflammation may warrant autoimmune screening or specialist referral.
If all results are genuinely optimal and PEM is present
Request a GP referral to your local ME/CFS specialist service. NICE NG206 states that diagnosis should be made within 3 months of symptom onset where possible, and referral should not wait for further investigations if the clinical picture is clear.
Keep a record
Track your results over time. Trends matter more than single snapshots. A ferritin that was 60 six months ago and is now 25 tells a story that a single reading of 25 cannot.
When to Retest
| Scenario | Retest Interval |
|---|---|
| Started iron supplementation | 8–12 weeks (ferritin recheck) |
| Started vitamin D supplementation | 3 months |
| Started levothyroxine | 6–8 weeks (TSH + FT4) |
| Dietary changes for inflammation | 3 months (hs-CRP recheck) |
| ME/CFS diagnosis, monitoring | 6–12 months (to catch new deficiencies) |
| Symptoms worsening | Immediately — don’t wait for scheduled retest |
Evidence-Based Interventions
These interventions have published evidence for improving specific biomarkers associated with chronic fatigue. They are not treatments for ME/CFS itself — they address the modifiable factors that compound fatigue.
Iron Supplementation
Evidence: BSH 2021: ferrous fumarate 210mg on alternate days optimises absorption. IV iron for non-responders. Target ferritin ≥50 µg/L.
Markers improved: Ferritin, haemoglobin, MCV
Vitamin D3 + K2
Evidence: SACN 2016: 10 µg (400 IU) minimum, but 75–100 nmol/L is the target for symptom resolution. Most deficient patients need 3,000–4,000 IU daily for 3 months, then a maintenance dose.
Markers improved: 25-OH Vitamin D
B12 Replacement
Evidence: BSH 2014: IM hydroxocobalamin for confirmed deficiency, oral 1,000 µg daily for grey-zone levels. Sublingual methylcobalamin is an alternative when injections are refused.
Markers improved: Serum B12, methylmalonic acid
Mediterranean Dietary Pattern
Evidence: PREDIMED trial (NEJM 2018): anti-inflammatory diet reduces hs-CRP by 0.5–1.0 mg/L over 12 months. Consistent evidence across multiple RCTs for reduced systemic inflammation.
Markers improved: hs-CRP, ESR
Pacing (Activity Management)
Evidence: NICE NG206 (2021): pacing is the primary management recommendation for ME/CFS. Not a 'cure' but prevents PEM-driven deterioration. Replaced graded exercise therapy in the updated guideline.
Markers improved: Symptom stability (not a blood marker)
Sleep Hygiene
Evidence: NICE NG206: sleep management is part of the ME/CFS care plan. Consistent sleep-wake schedules, limiting daytime sleep to 30 minutes, and treating comorbid sleep disorders. Melatonin may help circadian disruption.
Markers improved: Cortisol diurnal rhythm (indirectly)
Frequently Asked Questions
What blood tests should I ask my GP for if I suspect ME/CFS?
Start with the NICE NG206 minimum: FBC, thyroid function (TSH), ESR or CRP, HbA1c, ferritin, coeliac serology (tTG-IgA), urea and electrolytes, liver function, calcium and phosphate, creatine kinase, and urinalysis. If these are all normal, ask about vitamin D, B12, morning cortisol, and ANA — these catch the conditions most commonly missed by the standard panel.
Can a blood test diagnose ME/CFS?
No. There is currently no blood test that diagnoses ME/CFS directly. Blood tests are used to rule out other conditions that cause similar symptoms. ME/CFS is diagnosed clinically based on symptoms (debilitating fatigue, post-exertional malaise, unrefreshing sleep, cognitive difficulties) that have persisted for at least 3 months and are not explained by another condition.
My blood tests are normal but I’m exhausted. What now?
First, check whether your results are genuinely optimal, not just 'in range'. A ferritin of 20, TSH of 4.0, and vitamin D of 30 are all technically normal but suboptimal for energy. If they are genuinely optimal, discuss your symptoms with your GP and request referral to a specialist ME/CFS service — NICE NG206 says this should not be delayed once the clinical picture is clear.
Is ME/CFS the same as long COVID?
They are distinct conditions with significant overlap. An estimated 50% of people with long COVID meet the diagnostic criteria for ME/CFS, particularly those with prominent post-exertional malaise. However, long COVID can also involve organ-specific damage (cardiac, pulmonary) that ME/CFS typically does not. The blood test workup is similar for both, but long COVID may warrant additional cardiac markers (troponin, BNP) and lung function testing.
Should I get tested during a crash or on a good day?
For baseline bloods, test on a typical day — not during a severe crash and not on your best day. Cortisol should always be tested at 9am fasted. For ferritin, avoid testing during acute illness (it rises as an acute-phase reactant and may mask true iron deficiency).
How much does private testing for chronic fatigue cost?
A comprehensive panel covering the key chronic fatigue biomarkers (thyroid, iron, inflammation, metabolic, nutritional) costs from £89 for a basic panel to £129 for a performance-level panel that includes FT3 and cortisol. Individual GP-requested tests on the NHS are free but may not include the full range needed.
Will my GP take private blood test results seriously?
Most GPs will review private results, though some may want to reconfirm abnormal findings with their own lab. The key is presenting results clearly and asking specific questions (‘my ferritin is 22 — can we discuss iron supplementation?’) rather than presenting a comprehensive panel and asking for a general opinion. UKAS-accredited private labs (which Helvy uses) produce results to the same analytical standard as NHS labs.
Stop guessing. Start with the right blood tests.
The Performance panel covers 8 of the 10 key chronic fatigue biomarkers — including FT3 and cortisol that standard NHS panels miss. Results in 5 working days. Reviewed by a GMC-registered doctor.
View the Performance PanelSOURCES & FURTHER READING
- NICE NG206: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (2021)
- NHS: Chronic fatigue syndrome (CFS/ME)
- NICE CG145: Thyroid disease assessment and management
- BSH Guideline on Iron Deficiency in Adults (2021)
- NICE NG20: Coeliac disease — recognition, assessment and management
- NICE NG28: Type 2 diabetes in adults — management
- Endocrine Society: Primary Adrenal Insufficiency (2016)
- BMJ Best Practice: Chronic fatigue syndrome
- Lancet Neurology 2020: Immunological dysfunction in ME/CFS
- SACN Vitamin D and Health Report (2016)